The generics market is growing, driven by rising healthcare costs and fed by a steady stream of patent expiries. Levels of generic uptake vary widely across the 7 major markets, with important implications for industry strategy.

Scope

An overview of the generics industry across the 7 major markets. Coverage of regulatory and commercial developments within the generics industry. Analysis of the impact of new events on the key stakeholders. Benchmarking recent generics company acquisitions and divestments.

Highlights

The intensely competitive environment of the generics market is behind the wave of consolidations that has resulted in a reshuffle of the top 10 generics companies globally. Competitive pressures have forced some generics companies out of the more mature markets, while others have adopted novel strategies to survive. Several of the less mature markets, particularly Japan, in which generic uptake has historically been slow, are poised for growth, and as such present an attractive prospect for international players.

Reasons to Purchase

Gain an understanding of the major drivers and resistors to generic growth in each of the 7 major markets. Become aware of new issues in the generics industry, and how they influence the key players in that market. Gain insight into recent M&A activity, and the strategic rationale driving them.